JD Supra7h
FDA Relaxes Critical Positions on Use of Scientific Information in Off-Label Communications
On January 6, 2025, the US Food and Drug Administration (FDA) published final guidance titled “Communications From Firms to Health Care ...
Biomednewsbreaks Renovorx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...